Latest News about BIIB
Recent news which mentions BIIB
Earnings Scheduled For October 20, 2021
October 20, 2021
From Benzinga
From Benzinga
The Week Ahead In Biotech (Oct. 18-23): J&J, Biogen Kickstart Big Pharma Earnings, Regeneron-Sanofi, Roche Await FDA Decisions And IPOs
October 18, 2021
From Benzinga
Here’s ‘one of the most bullish signals’ ever for bitcoin that many investors may have missed
October 18, 2021
From MarketWatch
The Dow is on track for its best October in 6 years and third-quarter earnings are strong so far. What could go wrong?
October 16, 2021
From MarketWatch
2 Top Healthcare Stocks That Could Be Bought Out in 2022
October 16, 2021
From Motley Fool
3 Highly Profitable Stocks Wall Street Thinks Will Soar 39% or More
October 15, 2021
From Motley Fool
3 Top Healthcare Stocks That Could Rise More Than 40% in 12 Months
October 13, 2021
From Motley Fool
Why Humana Is Suing Biogen
October 09, 2021
From Motley Fool
Where to Invest $600 Right Now
October 09, 2021
From Motley Fool
Tickers
BIIB
From Motley Fool
3 Stocks to Buy Where Wall Street Is Focused on Fear
October 07, 2021
From InvestorPlace
3 Biotech Stocks That Could Make You Richer in October and Beyond
October 07, 2021
From Motley Fool
From Benzinga
Rising Oil Prices and Yields Makes Market Navigation More Complex
October 05, 2021
From Benzinga
Here's What to Do When a Stock You Own Sparks Controversy
October 05, 2021
From Motley Fool
Here's What Warren Buffett Looks For With Healthcare Stocks
October 02, 2021
From Motley Fool
Cassava Stock Has Reached a Positive Turning Point
October 01, 2021
From InvestorPlace
See Why Perrigo Shares Are Moving Higher On Thursday
September 30, 2021
From Benzinga
More than a quarter of Nasdaq-100 stocks are in bear markets — Wall Street sees a buying opportunity
September 29, 2021
From MarketWatch
3 Biotech Stocks With Huge Catalysts This Fall
September 29, 2021
From Motley Fool
Eisai, Biogen Initiate Rolling Submission For New Alzheimer's Drug
September 28, 2021
From Benzinga
The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive
September 28, 2021
From Benzinga
Is Cassava Sciences Back in the Game?
September 28, 2021
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
